Literature DB >> 18040287

Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export.

Yao Chen1, Hong Hai Li, Jing Fu, Xue Feng Wang, Yi Bin Ren, Li Wei Dong, Shan Hua Tang, Shu Qing Liu, Meng Chao Wu, Hong Yang Wang.   

Abstract

p28(GANK) (also known as PSMD10, p28 and gankyrin) is an ankyrin repeat anti-apoptotic oncoprotein that is commonly overexpressed in hepatocellular carcinomas and increases the degradation of p53 and Rb. NF-kappaB (nuclear factor-kappaB) is known to be sequestered in the cytoplasm by I kappaB (inhibitor of NF-kappaB) proteins, but much less is known about the cytoplasmic retention of NF-kappaB by other cellular proteins. Here we show that p28(GANK) inhibits NF-kappaB activity. As a nuclear-cytoplasmic shuttling protein, p28(GANK) directly binds to NF-kappaB/RelA and exports RelA from nucleus through a chromosomal region maintenance-1 (CRM-1) dependent pathway, which results in the cytoplasmic retention of NF-kappaB/RelA. We demonstrate that all the ankyrin repeats of p28(GANK) are required for the interaction with RelA and that the N terminus of p28(GANK), which contains the nuclear export sequence (NES), is responsible for suppressing NF-kappaB/RelA nuclear translocation. These results suggest that overexpression of p28(GANK) prevents the nuclear localization and inhibits the activity of NF-kappaB/RelA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040287     DOI: 10.1038/cr.2007.99

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  21 in total

1.  PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression.

Authors:  Tao Luo; Jing Fu; An Xu; Bo Su; Yibing Ren; Ning Li; Junjie Zhu; Xiaofang Zhao; Rongyang Dai; Jie Cao; Bibo Wang; Wenhao Qin; Jinhua Jiang; Juan Li; Mengchao Wu; Gensheng Feng; Yao Chen; Hongyang Wang
Journal:  Autophagy       Date:  2015-04-23       Impact factor: 16.016

Review 2.  Gankyrin as a potential target for tumor therapy: evidence and perspectives.

Authors:  Haixai Li; Junyan Zhang; Cheng Zhen; Baojun Yang; Limin Feng
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 3.  The nuclear signaling of NF-kappaB: current knowledge, new insights, and future perspectives.

Authors:  Fengyi Wan; Michael J Lenardo
Journal:  Cell Res       Date:  2009-12-08       Impact factor: 25.617

Review 4.  Gankyrin as a potential therapeutic target for cancer.

Authors:  Chongchong Wang; Li Cheng
Journal:  Invest New Drugs       Date:  2017-05-19       Impact factor: 3.850

5.  RNA Binding Protein CUGBP1 Inhibits Liver Cancer in a Phosphorylation-Dependent Manner.

Authors:  Kyle Lewis; Leila Valanejad; Ashley Cast; Mary Wright; Christina Wei; Polina Iakova; Lauren Stock; Rebekah Karns; Lubov Timchenko; Nikolai Timchenko
Journal:  Mol Cell Biol       Date:  2017-07-28       Impact factor: 4.272

6.  Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.

Authors:  J Chen; M Bai; C Ning; B Xie; J Zhang; H Liao; J Xiong; X Tao; D Yan; X Xi; X Chen; Y Yu; R C Bast; Z Zhang; Y Feng; W Zheng
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

Review 7.  Gankyrin regulates cell signaling network.

Authors:  Xinxin Wang; Bin Jiang; Yanjie Zhang
Journal:  Tumour Biol       Date:  2016-01-27

8.  p28GANK overexpression is associated with chemotherapy resistance and poor prognosis in ovarian cancer.

Authors:  Ge Yu; Na Li; Wei Wang; Ming Niu; Xiaoling Feng
Journal:  Oncol Lett       Date:  2019-11-13       Impact factor: 2.967

9.  Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.

Authors:  X Zhao; J Fu; A Xu; L Yu; J Zhu; R Dai; B Su; T Luo; N Li; W Qin; B Wang; J Jiang; S Li; Y Chen; H Wang
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

10.  The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations.

Authors:  Xavier Bisteau; Matias J Caldez; Philipp Kaldis
Journal:  Cancers (Basel)       Date:  2014-01-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.